Fabentech

Biotech & Life Sciences · Lyon, France · Founded 2009

Specializes in the development and production of emergency treatments to combat the risks of bioterrorism and emerging infectious diseases that are priorities for public health MoreLess

Specializes in the development and production of emergency treatments to combat the risks of bioterrorism and emerging infectious diseases that are priorities for public health

Valuation $0–100M

Headcount <100

Total funding $10–50M

Unlock exact values

Talent graph

Fabentech's talent

Book a demo to see the people

Team profiled 6 named & role-tagged

Founders /100 quality score

Key operators 2 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Fabentech's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Auriga Partners

Rhone-Alpes Creation

Trail Solutions Patrimoine

Series B+ 5 investors entered at this stage

Bpifrance

Elaia

Kreaxi

Institut Mérieux

European Investment Bank

Global footprint

Where Fabentech has talent and traffic

Workforce by country

1 countries with
team presence

🇫🇷 France100%

1 country shown

Market sentiment

What the market is saying about Fabentech

An AI-synthesized read of the highest-engagement posts about Fabentech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fabentech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles